Description
Antibody immunodeficiency disorders — such as multiple myeloma, HIV infection, solid organ tumors, or chronic liver disease — are a spectrum of diseases characterized by decreased immunoglobulin levels. Disease states can range from deficiency of a single class or subclass to the complete absence of all classes of immunoglobulin. Luminex® xMAP® technology is of great help in the diagnosis of these disorders, as it enables simultaneous quantification of immunoglobulin isotypes.

This technology is also ideal for researchers seeking to measure overall levels of certain isotypes in particular diseases or disease, such as various IgG deficiencies related to responder/nonresponder status, increased or unusual allergies, autoimmune diseases, GI disorders, malignancies, chest symptoms, or recurrent bacterial infections. Using xMAP technology helps reduce the number of tests that must be performed and eliminates the potential for inaccurate results due to the inherent variability of multiple, separate tests.